Workflow
West Announces Second-Quarter Dividend
WSTWest Pharmaceutical(WST) Prnewswire·2025-02-20 21:30

Core Viewpoint - West Pharmaceutical Services, Inc. announced a second-quarter 2025 dividend of 0.21pershare,reflectingthecompany′scommitmenttoreturningvaluetoshareholders[1].CompanyOverview−WestPharmaceuticalServices,Inc.isaleadingproviderofinnovative,high−qualityinjectablesolutionsandservices,supportingbothestablishedandemergingdrugdevelopers[2].−Thecompanyemploysover10,000teammembersacross50sites,including25manufacturingfacilitiesglobally,deliveringover41billioncomponentsanddevicesannually[2].−Infiscalyear2024,Westgenerated0.21 per share, reflecting the company's commitment to returning value to shareholders [1]. Company Overview - West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services, supporting both established and emerging drug developers [2]. - The company employs over 10,000 team members across 50 sites, including 25 manufacturing facilities globally, delivering over 41 billion components and devices annually [2]. - In fiscal year 2024, West generated 2.89 billion in net sales and is listed on the New York Stock Exchange (NYSE: WST) as well as included in the Standard & Poor's 500 index [3].